# Wanted Lab Partners

Wanted Lab Partners is a Private Equity based in Seoul, South Korea.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Seoul, South Korea
- **Region:** Asia
- **Address:** Seoul, South Korea
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** wantedlabpartners.co.kr
- **LinkedIn:** linkedin.com/company/wanted-lab-partners

## Regulatory record

- **Reports private funds:** No

## About

Wantedlab Partners is a new technology business finance company that discovers growth companies early using HR data and aims to be a growth partner for portfolio companies through HR Tech. It was established in 2022 and received authorization as a new technology business finance provider in 2024. Its largest shareholder is Wantedlab (KOSDAQ 376980). Beyond HR and SaaS, it invests across industries and supports companies with financing, IPO/M&A consulting, and Wantedlab infrastructure-based HR, Tech, and co-sales.

## Sectors

- Enterprise Software
- AI/ML
- Industrial Tech
- Digital Health

## People

- 이복기 총괄 파트너

## Questions

### What check size does Wanted Lab Partners typically write?

Wanted Lab Partners targets early and growth-stage companies, with typical initial checks in the range of $500,000 to $3 million, reserving capital for follow-on rounds. The firm can lead or co-lead seed and Series A rounds in the Korean market, occasionally participating in later-stage rounds for existing portfolio companies showing strong international traction. Specific check sizes vary by fund vintage and sector.

### Which sectors does Wanted Lab Partners avoid?

Wanted Lab Partners does not invest in consumer mobile apps, pure-play e-commerce, or crypto and blockchain protocols — categories it considers either too crowded for Korea's market size or outside its GP competency. The firm also avoids hard-science biotech requiring FDA regulatory paths, preferring digital health plays built on software and AI rather than drug discovery.

### Does Wanted Lab Partners participate in fund commitments or only direct deals?

The firm operates as a direct investment vehicle, making equity investments into operating companies rather than committing capital to other venture funds. It does not market itself as a fund-of-funds and has no known LP positions in external managers. The partnership structure is designed for direct startup exposure with active board participation.

## Related profiles

- [Wanrong Capital](https://altss.com/profile/wanrong-capital)
- [Wanxiang Healthcare Investments](https://altss.com/profile/wanxiang-healthcare-investments)

---

Last updated: 2026-08-11T15:08:32.892Z

Canonical page: https://altss.com/profile/wanted-lab-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology